Hyoscine-Butylbromide Used During Laparoscopic Sleeve Gastrectomy Increases Removed Gastric Volume

Abstract

Aim: Obesity is one of the most common diseases, The main goal in bariatric surgeries is to reduce the gastric volume. Also, studies have linked reduced abdominal volume and weight loss. Our aim in this study is to investigate intraoperatively administered hyoscine butylbromide(HBB) on the removed gastric volüme(RGV). Material and Methods: The study, which was planned as a retrospective cohort study, included 67 patients who underwent laparoscopic sleeve gastrectomy (LSG). HBB at a dose of 20 mg was given to 32 patients preoperatively(Group II). A similar procedure was applied to 35 patients in the control group(Group I), but HBB was not given. Demographic characteristics, body mass indexes, and laboratory values of the patients were recorded. Weight loss and changes in BMI were recorded at the first and sixth month controls. Data were analyzed for normality of distribution with the Shapiro-Wilk test. Non-parametric values for general differences between groups were analyzed with the Mann-Whitney U test and parametric values were analyzed with Student t-test . Results: In Group II, the removed gastric volume was greater. In the first and sixth month BMI, there was a significant difference between the groups. Group II lost more weight statistically, and as a result, their BMI decreased significantly. Conclusion: It was observed that inexpensive and easily accessible HBB increased the removed gastric volume in bariatric surgery and contributed to weight loss.